|
US6387373B1
(en)
*
|
1993-01-15 |
2002-05-14 |
Novavax, Inc. |
Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
|
|
US6542183B1
(en)
|
1995-06-28 |
2003-04-01 |
Lynx Systems Developers, Inc. |
Event recording apparatus
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US6958148B1
(en)
*
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
KR100342835B1
(ko)
*
|
1998-07-31 |
2002-07-02 |
박호군 |
유전자 또는 약물을 효과적으로 전달하는 지방유제, 제형 및 이들의 제조방법
|
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
|
US20020054914A1
(en)
*
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
|
US20040258763A1
(en)
*
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
WO2000046147A2
(en)
|
1999-02-03 |
2000-08-10 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US7655252B2
(en)
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US8236335B2
(en)
|
1999-04-28 |
2012-08-07 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
ATE485837T1
(de)
|
2000-08-03 |
2010-11-15 |
Antares Pharma Ipl Ag |
Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
|
|
US6423707B1
(en)
|
2000-08-28 |
2002-07-23 |
California Pacific Medical Center |
Nitroimidazole ester analogues and therapeutic applications
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US6537591B2
(en)
|
2001-03-02 |
2003-03-25 |
Aquarium Pharmaceuticals, Inc. |
Aquatic animal treatment method and composition containing Pimenta extract
|
|
US20030185892A1
(en)
*
|
2001-08-17 |
2003-10-02 |
Bell Steve J. D. |
Intraocular delivery compositions and methods
|
|
BR0212163A
(pt)
*
|
2001-08-28 |
2004-12-07 |
Eden Reseaech Plc |
Composição para tratamento ou prevenção de infecção em plantas
|
|
US6878693B2
(en)
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US8663687B2
(en)
*
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
|
US20030180349A1
(en)
*
|
2001-12-07 |
2003-09-25 |
Franklin Lanny U. |
Respiratory infection prevention and treatment with terpene-containing compositions
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
AU2003223183A1
(en)
*
|
2002-02-19 |
2003-09-09 |
Eden Researach Plc |
Improvement of indoor air quality and antiseptic composition for use therein
|
|
WO2003070181A2
(en)
*
|
2002-02-19 |
2003-08-28 |
Eden Research Plc |
Compositions and methods for preservation of food
|
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
ATE534373T1
(de)
|
2003-10-10 |
2011-12-15 |
Antares Pharma Ipl Ag |
Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut
|
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
|
US20050084456A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Liping Tang |
Functionalized particles
|
|
PT3659437T
(pt)
|
2004-01-23 |
2022-06-20 |
Eden Research Plc |
Métodos para matar nemátodos que compreendem a aplicação de um componente terpeno encapsulado
|
|
US7651694B2
(en)
*
|
2004-02-13 |
2010-01-26 |
Nod Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of making and using same
|
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
EP2338332B1
(en)
|
2004-05-20 |
2014-02-12 |
Eden Research Plc |
Hollow glucan particle or cell wall particle encapsulating a terpene component
|
|
US20060067977A1
(en)
|
2004-09-28 |
2006-03-30 |
Atrium Medical Corporation |
Pre-dried drug delivery coating for use with a stent
|
|
US9592324B2
(en)
|
2006-11-06 |
2017-03-14 |
Atrium Medical Corporation |
Tissue separating device with reinforced support for anchoring mechanisms
|
|
EP1811935B1
(en)
|
2004-09-28 |
2016-03-30 |
Atrium Medical Corporation |
Heat cured gel and method of making
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
CA2586035A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles in use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
WO2006113668A1
(en)
*
|
2005-04-15 |
2006-10-26 |
University Of South Florida |
A method of transdermal drug delivery using hyaluronic acid nanoparticles
|
|
US8067399B2
(en)
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
US20080274195A1
(en)
|
2005-07-18 |
2008-11-06 |
University Of Massachusetts Lowell |
Compositions and Methods for Making and Using Nanoemulsions
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
GEP20125432B
(en)
|
2005-10-12 |
2012-03-26 |
Unimed Pharmaceuticals Llc |
Improved testosterone gel and use thereof
|
|
KR101359723B1
(ko)
|
2005-10-18 |
2014-02-05 |
노바백스, 인코포레이티드 |
기능성 인플루엔자 바이러스 유사 입자들
|
|
EP2982244B1
(en)
|
2005-11-30 |
2020-11-18 |
Eden Research Plc |
Insecticidal capsules containing thymol and methods of making and using them
|
|
JP6027718B2
(ja)
|
2005-11-30 |
2016-11-16 |
エーデン リサーチ ピーエルシー |
チモール、オイゲノール、ゲラニオール、シトラール、及びｌ−カルボンから選択されたテルペン又はテルペン混合物を含む組成物及び方法
|
|
KR102110379B1
(ko)
|
2005-12-01 |
2020-05-14 |
유니버시티 오브 메사츄세츠 로웰 |
보툴리눔 나노에멀젼
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
EP2001439A2
(en)
*
|
2006-03-07 |
2008-12-17 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
|
US10137083B2
(en)
*
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
|
WO2007123790A1
(en)
*
|
2006-04-07 |
2007-11-01 |
Novavax, Inc. |
Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
|
|
CN101426475A
(zh)
*
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
|
US9040250B2
(en)
*
|
2006-09-07 |
2015-05-26 |
The United States Of America, As Represented By The Secretary Of The Navy |
Binding interaction of proanthocyanidins with bacteria and bacterial components
|
|
US20080139513A1
(en)
*
|
2006-09-26 |
2008-06-12 |
Novavax, Inc. |
Transdermal deliver of active agents
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
SG177184A1
(en)
|
2006-12-01 |
2012-01-30 |
Anterios Inc |
Amphiphilic entity nanoparticles
|
|
SG179457A1
(en)
|
2006-12-01 |
2012-04-27 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
US20080207756A1
(en)
*
|
2007-02-27 |
2008-08-28 |
Atrium Medical Corporation |
Bio-absorbable oil suspension
|
|
WO2008137747A1
(en)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
CN101765423B
(zh)
|
2007-05-31 |
2014-08-06 |
安特里奥公司 |
核酸纳米粒子和其用途
|
|
US20110008838A1
(en)
|
2007-07-19 |
2011-01-13 |
Gale Smith |
Chimeric varicella zoster virus virus-like particles
|
|
KR101848095B1
(ko)
*
|
2008-06-26 |
2018-04-11 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
PL2370099T3
(pl)
|
2008-12-09 |
2016-10-31 |
|
Zmodyfikowane białka F RSV i sposoby ich zastosowania
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
SG10201401297QA
(en)
|
2009-04-08 |
2014-08-28 |
Cadila Healthcare Ltd |
Stable pharmaceutical compositions of diclofenac
|
|
US8470304B2
(en)
|
2009-08-04 |
2013-06-25 |
Avidas Pharmaceuticals Llc |
Therapeutic vitamin D sun-protecting formulations and methods for their use
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
US20110045050A1
(en)
*
|
2009-08-24 |
2011-02-24 |
Atrium Medical Corporation |
Nanoemulsion formulations for direct delivery
|
|
US10322213B2
(en)
|
2010-07-16 |
2019-06-18 |
Atrium Medical Corporation |
Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
US9789123B2
(en)
|
2010-10-21 |
2017-10-17 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
|
|
US20130295145A1
(en)
|
2010-10-21 |
2013-11-07 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising etodolac
|
|
US10028972B2
(en)
|
2010-10-21 |
2018-07-24 |
Cadila Healthcare Limited |
Pharmaceutical compositions of anti-acne agents
|
|
MX2013004296A
(es)
|
2010-10-21 |
2013-09-26 |
Cadila Healthcare Ltd |
Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
|
|
WO2012053012A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising tfflocolchicoside
|
|
WO2012053009A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Pharmaceutical compositions comprising skin whitening agents
|
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
|
WO2012059936A1
(en)
|
2010-11-03 |
2012-05-10 |
Padma Venkitachalam Devarajan |
Pharmaceutical compositions for colloidal drug delivery
|
|
KR101847908B1
(ko)
|
2010-11-05 |
2018-04-11 |
노바백스, 인코포레이티드 |
광견병 당단백질 바이러스-유사 입자(VLPs)
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
EP3263121B1
(en)
|
2010-12-21 |
2019-02-27 |
Leidos, Inc. |
Methods and compositions for wound treatment
|
|
US20120189677A1
(en)
*
|
2011-01-20 |
2012-07-26 |
Stephen Tonge |
Formulations
|
|
WO2012127496A1
(en)
|
2011-03-01 |
2012-09-27 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of lornoxicam or salts thereof
|
|
US11065206B2
(en)
|
2011-06-29 |
2021-07-20 |
Avidas Pharmaceuticals, LLC |
Topical formulations including lipid microcapsule delivery vehicles and their uses
|
|
WO2013014680A1
(en)
|
2011-07-28 |
2013-01-31 |
Cadila Healthcare Limited |
Method for treatment of pain and inflammation
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US8633178B2
(en)
|
2011-11-23 |
2014-01-21 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10322089B2
(en)
*
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
GB201220940D0
(en)
|
2012-11-21 |
2013-01-02 |
Eden Research Plc |
Method P
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
BR112016006122B1
(pt)
|
2013-09-19 |
2023-11-14 |
Novavax, Inc |
COMPOSIÇÃO IMUNOGÊNICA COMPREENDENDO UMA NANOPARTÍCULA DO CORONAVÍRUS DA SÍNDROME RESPIRATÓRIA DO ORIENTE MÉDIO (MERS-CoV)
|
|
EP3145489A1
(en)
|
2014-05-22 |
2017-03-29 |
TherapeuticsMD, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
CN111700877A
(zh)
|
2014-09-03 |
2020-09-25 |
吉倪塞思公司 |
治疗性纳米粒子和相关的组合物、方法和系统
|
|
US10894024B2
(en)
*
|
2014-12-08 |
2021-01-19 |
Synaptamine, Inc. |
Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
CA2996007A1
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
|
US12427121B2
(en)
|
2016-05-05 |
2025-09-30 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
US12433850B2
(en)
|
2016-05-05 |
2025-10-07 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine and prodrug compositions
|
|
WO2017192921A1
(en)
|
2016-05-05 |
2017-11-09 |
Monosol Rx, Llc |
Enhanced delivery epinephrine compositions
|
|
MX2019005833A
(es)
|
2016-11-21 |
2019-10-30 |
Eirion Therapeutics Inc |
Administracion transdermica de agentes grandes.
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
JP7317796B2
(ja)
|
2017-07-24 |
2023-07-31 |
ノババックス，インコーポレイテッド |
呼吸器疾患を治療するための方法および組成物
|
|
WO2020018974A1
(en)
|
2018-07-20 |
2020-01-23 |
Lipocine Inc. |
Liver disease
|
|
CN110881462A
(zh)
*
|
2019-11-25 |
2020-03-17 |
南京启佑生物科技有限公司 |
一种基于磷酸盐与金属离子的纳米农药复合制剂及其制备方法
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
US12465564B2
(en)
|
2021-10-25 |
2025-11-11 |
Aquestive Therapeutics, Inc. |
Oral and nasal compositions and methods of treatment
|
|
US20250085282A1
(en)
|
2023-09-11 |
2025-03-13 |
Novavax, Inc. |
Method for detecting anti-sars-cov-2 spike (s) immunoglobulins
|
|
US20250144200A1
(en)
|
2023-11-06 |
2025-05-08 |
Novavax, Inc. |
Intranasal immunogenic compositions
|